Aphranel® MagiCCrystal CaHA Filler Achieves EU MDR Certification as a Premium Regenerative Injectable
SHANGHAI, May 28, 2026 /PRNewswire/ -- Moyom Biotechnology announced that its premium regenerative aesthetics product, Aphranel® MagiCCrystal CaHA Filler officially achieved European Union Medical Device Regulation (EU MDR) certification on May 18,...
Aphranel Hosts "The Poetics of Time" Cultural Forum at Rome Exhibition in Shanghai
Where Regenerative Aesthetics Meets Architecture, Fashion, and Cultural Philosophy SHANGHAI, May 20, 2026 /PRNewswire/ -- On May 6, Aphranel® hosted its "Twin Peaks Lecture" and immersive runway presentation beneath the dome of the Roma Roma...
Aphranel Named to Forbes China Beauty 100 List
SHANGHAI, March 13, 2026 /PRNewswire/ -- Aphranel, a China-origin regenerative medical aesthetics brand under the company SHANGHAI MOYANG BIOTECHNOLOGY, has been named to the Third Forbes China Beauty 100 list, published by Forbes China, which...
Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel's "Poetics of Time" Brand Positioning
SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- Moyom Biotechnology recently announced a strategic partnership with WPP Group, one of the world's leading global communications and creative networks. The partnership is centered on the "Poetics of Time" brand...